China Isotope & Radiation Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
China Isotope & Radiation has a total shareholder equity of CN¥7.3B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are CN¥13.7B and CN¥6.4B respectively. China Isotope & Radiation's EBIT is CN¥820.4M making its interest coverage ratio 163.9. It has cash and short-term investments of CN¥3.0B.
Anahtar bilgiler
27.4%
Borç/özkaynak oranı
CN¥2.01b
Borç
| Faiz karşılama oranı | 163.9x |
| Nakit | CN¥3.01b |
| Eşitlik | CN¥7.33b |
| Toplam yükümlülükler | CN¥6.42b |
| Toplam varlıklar | CN¥13.74b |
Son finansal sağlık güncellemeleri
China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28
China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Recent updates
China Isotope & Radiation Corporation's (HKG:1763) 36% Share Price Surge Not Quite Adding Up
Oct 07China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think
May 05Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price
Apr 26China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
May 13Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Feb 07China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends
Dec 20A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)
Oct 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
Aug 30Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?
Jun 10China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?
Dec 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal
Oct 08Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?
Sep 05Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture
Jun 13When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?
May 24China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)
Mar 14The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More
Feb 04
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Jan 09Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 1763's short term assets (CN¥8.5B) exceed its short term liabilities (CN¥4.4B).
Uzun Vadeli Yükümlülükler: 1763's short term assets (CN¥8.5B) exceed its long term liabilities (CN¥2.0B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 1763 has more cash than its total debt.
Borcun Azaltılması: 1763's debt to equity ratio has increased from 5.6% to 27.4% over the past 5 years.
Borç Kapsamı: 1763's debt is not well covered by operating cash flow (12.9%).
Faiz Kapsamı: 1763's interest payments on its debt are well covered by EBIT (163.9x coverage).